Recent advances in head and neck cancer

N Engl J Med. 2008 Sep 11;359(11):1143-54. doi: 10.1056/NEJMra0707975.

Authors

Robert I Haddad¹, Dong M Shin

Affiliation

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. robert_haddad@dfci.harvard.edu

PMID: 18784104
DOI: 10.1056/NEJMra0707975

No abstract available

MeSH terms

Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Carcinoma, Squamous Cell / etiology
Carcinoma, Squamous Cell / physiopathology
Carcinoma, Squamous Cell / therapy*
Cetuximab
Combined Modality Therapy
Disease Progression
ErbB Receptors / physiology
Genomic Instability
Head and Neck Neoplasms / etiology
Head and Neck Neoplasms / physiopathology
Head and Neck Neoplasms / therapy*
Human papillomavirus 16
Humans
Papillomavirus Infections / complications
Radiotherapy
Signal Transduction

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
ErbB Receptors
Cetuximab